Farther Finance Advisors »

Enliven Therapeutics shares owned by Farther Finance Advisors

Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Farther Finance Advisors from 13F filings

Historical chart of Farther Finance Advisors investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by Farther Finance Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by Farther Finance Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $153 6 25.50
2024-06-30 $136 6 22.67
2024-03-31 $112 6 18.83
2023-12-31 $82 6 13.83

More positions owned by Farther Finance Advisors

Ishares Core S&p 500 Etf Etf (IVV)
Vanguard S&p 500 Etf Etf (VOO)
Nvidia Corporation Stock (NVDA)
Apple Stock (AAPL)
Ishares Core Total Usd Bond Market Etf Etf (IUSB)
Microsoft Corp Stock (MSFT)
Uva Unconstrained Medium-term Fixed Income Etf Etf (FFIU)
Ishares National Muni Bond Etf Etf (MUB)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Vanguard Intermediate-term Bond Etf Etf (BIV)
Spdr S&p 500 Etf Trust Etf (SPY)
Ishares Msci Usa Quality Factor Etf Etf (QUAL)
Amazon Stock (AMZN)
Ishares Core S&p Small Cap Etf Etf (IJR)
Ishares S&p 500 Growth Etf Etf (IVW)

View all positions for Farther Finance Advisors

Top funds holding Enliven Therapeutics

OrbiMed Advisors
Commodore Capital
VR Adviser
Fairmount Funds Management
BlackRock
BlackRock
Vanguard Group
5AM Venture Management
Citadel Advisors
RA Capital Management
Pictet Asset Management Holding SA
Woodline Partners
Soleus Capital Management
Geode Capital Management
Henderson Group

View all funds holding Enliven Therapeutics